Marcus Hompesch, M.D.
Marcus is Founder, President and CEO of Profil Institute for Clinical Research in San Diego. Over the past decade, Profil has been involved with almost every clinically promising drug and device development in diabetes (175+ trials). Dr. Hompesch is an expert in the field of metabolic diseases, a licensed physician, and an entrepreneur. He spent 8 years as a practicing physician and has been involved in designing, performing and publishing many clinical studies in metabolic diseases—particularly early-phase diabetes studies. He received his M.D. from the U. of Düsseldorf, Germany. Dr. Hompesch was the founder of Med.IQ, a company that developed electronic patient records and disease-management tools for patients with diabetes, which he led as CEO until a successful exit event in 2000.